SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    G. Sapisochin, C. Rodríguez de Lope, M. Gastaca, J. Ortiz de Urbina, M. A. Suarez, J. Santoyo, J. F. Castroagudín, E. Varo, R. López-Andujar, F. Palacios, G. Sanchez Antolín, B. Perez, A. Guiberteau, G. Blanco, M. L. González-Diéguez, M. Rodriguez, M. A. Varona, M. A. Barrera, Y. Fundora, J. A. Ferron, E. Ramos, J. Fabregat, R. Ciria, S. Rufian, A. Otero, M. A. Vazquez, J. A. Pons, P. Parrilla, G. Zozaya, J. I. Herrero, R. Charco, J. Bruix, Very Early” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?, American Journal of Transplantation, 2014, 14, 3
  2. 2
    Jing Xu, Dajing Li, Xiaowu Li, Zipei Liu, Tianyu Li, Peng Jiang, Qiang He, Feng Tian, Yang Gao, Dechun Wang, Shuguang Wang, 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma, Digestive and Liver Disease, 2014, 46, 8, 750

    CrossRef

  3. 3
    Amy L. Collins, Sylwia Wojcik, James Liu, Wendy L. Frankel, Hansjuerg Alder, Lianbo Yu, Thomas D. Schmittgen, Carlo M. Croce, Mark Bloomston, A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma, Annals of Surgical Oncology, 2014, 21, 1, 133

    CrossRef

  4. 4
    Wei Liu, Feng Tian, Peng Jiang, Xin Zhao, Fei Guo, Xiaowu Li, Shuguang Wang, Aberrant expression of laminin γ2 correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma, Journal of Surgical Research, 2014, 186, 1, 150

    CrossRef

  5. 5
    H. Takahashi, H. Ojima, H. Shimizu, J. Furuse, H. Furukawa, T. Shibata, Axitinib (AG-013736), an Oral Specific VEGFR TKI, Shows Potential Therapeutic Utility Against Cholangiocarcinoma, Japanese Journal of Clinical Oncology, 2014, 44, 6, 570

    CrossRef

  6. You have free access to this content6
    Valérie Untereiner, Ganesh Dhruvananda Sockalingum, Roselyne Garnotel, Cyril Gobinet, Fidy Ramaholimihaso, Florent Ehrhard, Marie-Danièle Diebold, Gérard Thiéfin, Bile analysis using high-throughput FTIR spectroscopy for the diagnosis of malignant biliary strictures: a pilot study in 57 patients, Journal of Biophotonics, 2014, 7, 3-4
  7. 7
    Kassaporn Duangkumpha, Anchalee Techasen, Watcharin Loilome, Nisana Namwat, Raynoo Thanan, Narong Khuntikeo, Puangrat Yongvanit, BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma, Tumor Biology, 2014,

    CrossRef

  8. You have free access to this content8
    Atit Silsirivanit, Kanlayanee Sawanyawisuth, Gregory J. Riggins, Chaisiri Wongkham, Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches, Journal of Hepato-Biliary-Pancreatic Sciences, 2014, 21, 6
  9. 9
    Nataliya Razumilava, Gregory J Gores, Cholangiocarcinoma, The Lancet, 2014, 383, 9935, 2168

    CrossRef

  10. 10
    Rocio I. R. Macias, Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives, ISRN Hepatology, 2014, 2014, 1

    CrossRef

  11. 11
    Rondell P. Graham, Emily G. Barr Fritcher, Ekaterina Pestova, John Schulz, Leonid A. Sitailo, George Vasmatzis, Stephen J. Murphy, Robert R. McWilliams, Steven N. Hart, Kevin C. Halling, Lewis R. Roberts, Gregory J. Gores, Fergus J. Couch, Lizhi Zhang, Mitesh J. Borad, Benjamin R. Kipp, Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma, Human Pathology, 2014, 45, 8, 1630

    CrossRef

  12. 12
    E. G. Barr Fritcher, B. R. Kipp, K. C. Halling, A. C. Clayton, FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology, Cytopathology, 2014, 25, 4
  13. 13
    Udayakumar Navaneethan, Basile Njei, Preethi G.K. Venkatesh, John J. Vargo, Mansour A. Parsi, Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis, Gastrointestinal Endoscopy, 2014, 79, 6, 943

    CrossRef

  14. 14
    Xin Chen, Diego F. Calvisi, Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research, The American Journal of Pathology, 2014, 184, 4, 912

    CrossRef

  15. 15
    Guo-Wei Zhang, Jian-Hua Lin, Jian-Ping Qian, Jie Zhou, Identification of Risk and Prognostic Factors for Patients with Clonorchiasis-Associated Intrahepatic Cholangiocarcinoma, Annals of Surgical Oncology, 2014,

    CrossRef

  16. 16
    G. Sapisochin, C. Rodríguez de Lope, M. Gastaca, J. Ortiz de Urbina, R. López-Andujar, F. Palacios, E. Ramos, J. Fabregat, J. F. Castroagudín, E. Varo, J. A. Pons, P. Parrilla, M. L. González-Diéguez, M. Rodriguez, A. Otero, M. A. Vazquez, G. Zozaya, J. I. Herrero, G. Sanchez Antolin, B. Perez, R. Ciria, S. Rufian, Y. Fundora, J. A. Ferron, A. Guiberteau, G. Blanco, M. A. Varona, M. A. Barrera, M. A. Suarez, J. Santoyo, J. Bruix, R. Charco, Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation, Annals of Surgery, 2014, 259, 5, 944

    CrossRef

  17. 17
    Udayakumar Navaneethan, Norma G Gutierrez, Preethi GK Venkatesh, Ramprasad Jegadeesan, Renilang Zhang, Sunguk Jang, Madhusudhan R Sanaka, John J Vargo, Mansour A Parsi, Ariel E Feldstein, Tyler Stevens, Lipidomic Profiling of Bile in Distinguishing Benign From Malignant Biliary Strictures: A Single-Blinded Pilot Study, The American Journal of Gastroenterology, 2014, 109, 6, 895

    CrossRef

  18. 18
    Chinbold Enkhbold, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saito, Daichi Ishikawa, Mitsuo Shimada, Loss of FBXW7 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma, Hepatology Research, 2014, 44, 8
  19. 19
    Sophie Duignan, Donal Maguire, Chamarajanagar S. Ravichand, Justin Geoghegan, Emir Hoti, David Fennelly, John Armstrong, Kathy Rock, Helen Mohan, Oscar Traynor, Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience, HPB, 2014, 16, 1
  20. 20
    Fan Zhou, Jiewei Xu, Guoping Ding, Liping Cao, Overexpressions of CK2β and XIAP are Associated with Poor Prognosis of Patients with Cholangiocarcinoma, Pathology & Oncology Research, 2014, 20, 1, 73

    CrossRef

  21. 21
    Albert Amini, T. Clark Gamblin, Palliation, Surgical Oncology Clinics of North America, 2014, 23, 2, 383

    CrossRef

  22. 22
    Takao Nishikawa, Toshio Tsuyuguchi, Yuji Sakai, Harutoshi Sugiyama, Takashi Kishimoto, Masayuki Ohtsuka, Masaru Miyazaki, Osamu Yokosuka, Preoperative assessment of longitudinal extension of cholangiocarcinoma with peroral video-cholangioscopy: A prospective study, Digestive Endoscopy, 2014, 26, 3
  23. 23
    Ana Ruiz, Sara Lemoinne, Fabrice Carrat, Christophe Corpechot, Olivier Chazouillères, Lionel Arrivé, Radiologic course of primary sclerosing cholangitis: Assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression, Hepatology, 2014, 59, 1
  24. You have free access to this content24
    Puangrat Yongvanit, Somchai Pinlaor, Watcharin Loilome, Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma, Journal of Hepato-Biliary-Pancreatic Sciences, 2014, 21, 5
  25. 25
    Phil A. Hart, Ryan J. Law, Ross A. Dierkhising, Thomas C. Smyrk, Naoki Takahashi, Suresh T. Chari, Risk of Cancer in Autoimmune Pancreatitis, Pancreas, 2014, 43, 3, 417

    CrossRef

  26. 26
    M. Grunnet, M. Mau-Sørensen, Serum tumor markers in bile duct cancer – a review, Biomarkers, 2014, 19, 6, 437

    CrossRef

  27. 27
    Verena Keitel, Maria Reich, Dieter Häussinger, TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  28. 28
    M. Casper, M. Acalovschi, F. Lammert, V. Zimmer, The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer, Familial Cancer, 2014, 13, 2, 243

    CrossRef

  29. 29
    Hege Marie Vedeld, Kim Andresen, Ina Andrassy Eilertsen, Arild Nesbakken, Raquel Seruca, Ivar P. Gladhaug, Espen Thiis-Evensen, Torleiv O. Rognum, Kirsten Muri Boberg, Guro E. Lind, The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers, International Journal of Cancer, 2014, 135, 9
  30. 30
    Julie Le Faouder, Samira Laouirem, Theodore Alexandrov, Soundes Ben-Harzallah, Thibaut Léger, Miguel Albuquerque, Pierre Bedossa, Valérie Paradis, Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry, PROTEOMICS, 2014, 14, 7-8
  31. 31
    Teng-Yu Lee, Jaw-Town Lin, Ken N. Kuo, Ming-Shiang Wu, Hsiu J. Ho, Tzu-Ting Chen, Chun-Ying Wu, A nationwide population-based study shows increasing incidence of cholangiocarcinoma, Hepatology International, 2013, 7, 1, 226

    CrossRef

  32. 32
    Feng Tian, Dajiang Li, Jian Chen, Wei Liu, Lei Cai, Jianwei Li, Peng Jiang, Zipei Liu, Xin Zhao, Fei Guo, Xiaowu Li, Shuguang Wang, Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma, European Journal of Cancer, 2013, 49, 7, 1771

    CrossRef

  33. 33
    Charles Gabbert, Matthew Warndorf, Jeffrey Easler, Jennifer Chennat, Advanced Techniques for Endoscopic Biliary Imaging, Gastrointestinal Endoscopy Clinics of North America, 2013, 23, 3, 625

    CrossRef

  34. 34
    Michelle L. DeOliveira, Patryk Kambakamba, Pierre-Alain Clavien, Advances in liver surgery for cholangiocarcinoma, Current Opinion in Gastroenterology, 2013, 1

    CrossRef

  35. 35
    Qian He, Lei Cai, Ling Shuai, Dajiang Li, Cheng Wang, Yongkang Liu, Xiaowu Li, Zhihua Li, Shuguang Wang, Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21, Molecular Carcinogenesis, 2013, 52, 4
  36. 36
    Atsushi Suzuki, Artificial induction and disease-related conversion of the hepatic fate, Current Opinion in Genetics & Development, 2013, 23, 5, 579

    CrossRef

  37. 37
    Jiaqi Dai, Hongxia Wang, Ying Dong, Yinxin Zhang, Jian Wang, Bile Acids Affect the Growth of Human Cholangiocarcinoma via NF-kB Pathway, Cancer Investigation, 2013, 31, 2, 111

    CrossRef

  38. 38
    Nataliya Razumilava, Gregory J. Gores, Classification, Diagnosis, and Management of Cholangiocarcinoma, Clinical Gastroenterology and Hepatology, 2013, 11, 1, 13

    CrossRef

  39. 39
    Michael T. Dill, Luigi Tornillo, Thorsten Fritzius, Luigi Terracciano, David Semela, Bernhard Bettler, Markus H. Heim, Jan S. Tchorz, Constitutive Notch2 signaling induces hepatic tumors in mice, Hepatology, 2013, 57, 4
  40. 40
    Massimo Iavarone, Fabio Piscaglia, Sara Vavassori, Marzia Galassi, Angelo Sangiovanni, Laura Venerandi, Laura Virginia Forzenigo, Rita Golfieri, Luigi Bolondi, Massimo Colombo, Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis, Journal of Hepatology, 2013, 58, 6, 1188

    CrossRef

  41. 41
    Shinichi Aishima, Yohei Mano, Yuki Tanaka, Yuichiro Kubo, Ken Shirabe, Yoshihiko Maehara, Yoshinao Oda, Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma, Human Pathology, 2013, 44, 6, 1031

    CrossRef

  42. 42
    F Peng, J Jiang, Y Yu, R Tian, X Guo, X Li, M Shen, M Xu, F Zhu, C Shi, J Hu, M Wang, R Qin, Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis, British Journal of Cancer, 2013, 109, 12, 3092

    CrossRef

  43. 43
    Rui Li, Xiaohang Zhang, Kuan-Sheng Ma, Xiao-Wu Li, Feng Xia, Hua Zhong, Chun-lin Tang, Yanli Guo, Xiao-Chu Yan, Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: the influence of chronic hepatitis and cirrhosis, Abdominal Imaging, 2013, 38, 1, 112

    CrossRef

  44. 44
    Waraporn Chan-on, Maarja-Liisa Nairismägi, Choon Kiat Ong, Weng Khong Lim, Simona Dima, Chawalit Pairojkul, Kiat Hon Lim, John R McPherson, Ioana Cutcutache, Hong Lee Heng, London Ooi, Alexander Chung, Pierce Chow, Peng Chung Cheow, Ser Yee Lee, Su Pin Choo, Iain Bee Huat Tan, Dan Duda, Anca Nastase, Swe Swe Myint, Bernice Huimin Wong, Anna Gan, Vikneswari Rajasegaran, Cedric Chuan Young Ng, Sanjanaa Nagarajan, Apinya Jusakul, Shenli Zhang, Priya Vohra, Willie Yu, DaChuan Huang, Paiboon Sithithaworn, Puangrat Yongvanit, Sopit Wongkham, Narong Khuntikeo, Vajaraphongsa Bhudhisawasdi, Irinel Popescu, Steven G Rozen, Patrick Tan, Bin Tean Teh, Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers, Nature Genetics, 2013, 45, 12, 1474

    CrossRef

  45. 45
    Andreas Karakatsanis, Ioannis Papaconstantinou, Maria Gazouli, Anna Lyberopoulou, George Polymeneas, Dionysios Voros, Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance, Molecular Carcinogenesis, 2013, 52, 4
  46. 46
    Chen Li, Weixing Shen, Sheng Shen, Zhilong Ai, Gene expression patterns combined with bioinformatics analysis identify genes associated with cholangiocarcinoma, Computational Biology and Chemistry, 2013, 47, 192

    CrossRef

  47. 47
    Supak Yothaisong, Hasaya Dokduang, Anchalee Techasen, Nisana Namwat, Puangrat Yongvanit, Vajarabhongsa Bhudhisawasdi, Anucha Puapairoj, Gregory J. Riggins, Watcharin Loilome, Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy, Tumor Biology, 2013, 34, 6, 3637

    CrossRef

  48. 48
    Mona El Khatib, Anna Kalnytska, Vindhya Palagani, Uta Kossatz, Michael P. Manns, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz, Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma, Hepatology, 2013, 57, 3
  49. 49
    Daniela Sia, Yujin Hoshida, Augusto Villanueva, Sasan Roayaie, Joana Ferrer, Barbara Tabak, Judit Peix, Manel Sole, Victoria Tovar, Clara Alsinet, Helena Cornella, Brandy Klotzle, Jian–Bing Fan, Christian Cotsoglou, Swan N. Thung, Josep Fuster, Samuel Waxman, Juan Carlos Garcia–Valdecasas, Jordi Bruix, Myron E. Schwartz, Rameen Beroukhim, Vincenzo Mazzaferro, Josep M. Llovet, Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes, Gastroenterology, 2013, 144, 4, 829

    CrossRef

  50. 50
    D Sia, V Tovar, A Moeini, J M Llovet, Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, Oncogene, 2013, 32, 41, 4861

    CrossRef

  51. 51
    Maylee Hsu, Motoko Sasaki, Saya Igarashi, Yasunori Sato, Yasuni Nakanuma, KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas, Cancer, 2013, 119, 9
  52. 52
    Samuele De Minicis, Tatiana Kisseleva, Heather Francis, Gianluca Svegliati Baroni, Antonio Benedetti, David Brenner, Domenico Alvaro, Gianfranco Alpini, Marco Marzioni, Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma, Digestive and Liver Disease, 2013, 45, 6, 450

    CrossRef

  53. 53
    Marcin Krawczyk, Aksana Höblinger, Florentina Mihalache, Frank Grünhage, Monica Acalovschi, Frank Lammert, Vincent Zimmer, Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma, Digestive and Liver Disease, 2013, 45, 7, 612

    CrossRef

  54. 54
    Chiara Raggi, Pietro Invernizzi, Methylation and liver cancer, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 6, 564

    CrossRef

  55. 55
    Jinqiang Zhang, Chang Han, Hanqing Zhu, Kyoungsub Song, Tong Wu, miR-101 Inhibits Cholangiocarcinoma Angiogenesis through Targeting Vascular Endothelial Growth Factor (VEGF), The American Journal of Pathology, 2013, 182, 5, 1629

    CrossRef

  56. 56
    O. Farges, J. M. Regimbeau, D. Fuks, Y. P. Le Treut, D. Cherqui, P. Bachellier, J. Y. Mabrut, M. Adham, F. R. Pruvot, J. F. Gigot, Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma, British Journal of Surgery, 2013, 100, 2
  57. 57
    P Wang, Q Dong, C Zhang, P-F Kuan, Y Liu, W R Jeck, J B Andersen, W Jiang, G L Savich, T-X Tan, J T Auman, J M Hoskins, A D Misher, C D Moser, S M Yourstone, J W Kim, K Cibulskis, G Getz, H V Hunt, S S Thorgeirsson, L R Roberts, D Ye, K-L Guan, Y Xiong, L-X Qin, D Y Chiang, Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas, Oncogene, 2013, 32, 25, 3091

    CrossRef

  58. 58
    Sumera Rizvi, Gregory J. Gores, Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma, Gastroenterology, 2013, 145, 6, 1215

    CrossRef

  59. 59
    Massimiliano Cadamuro, Giorgia Nardo, Stefano Indraccolo, Luigi Dall'Olmo, Luisa Sambado, Lidia Moserle, Irene Franceschet, Michele Colledan, Marco Massani, Tommaso Stecca, Nicolò Bassi, Stuart Morton, Carlo Spirli, Romina Fiorotto, Luca Fabris, Mario Strazzabosco, Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma, Hepatology, 2013, 58, 3
  60. 60
    Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Svenja Sydor, Steven F. Bronk, John D. Christensen, Sumera H. Rizvi, Ali Canbay, Jürgen W. Treckmann, Andreas Paul, Alphonse E. Sirica, Gregory J. Gores, Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma, Hepatology, 2013, 58, 4
  61. 61
    Bing Wang, Rui Yang, Yue Wu, Hongbo Li, Zouxiao Hu, Yongjun Chen, Shengquan Zou, Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo, Gastroenterology Research and Practice, 2013, 2013, 1

    CrossRef

  62. 62
    K. Pak, S.-J. Kim, I. J. Kim, D. U. Kim, K. Kim, H. Kim, S. J. Kim, Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma, Nuklearmedizin, 2013, 53, 2, 26

    CrossRef

  63. 63
    Atsushi Kato, Hiroaki Shimizu, Masayuki Ohtsuka, Hiroyuki Yoshidome, Hideyuki Yoshitomi, Katsunori Furukawa, Dan Takeuchi, Tsukasa Takayashiki, Fumio Kimura, Masaru Miyazaki, Surgical Resection after Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer: A Retrospective Single-center Study, Annals of Surgical Oncology, 2013, 20, 1, 318

    CrossRef

  64. 64
    Verena Keitel, Dieter Häussinger, TGR5 in cholangiocytes, Current Opinion in Gastroenterology, 2013, 29, 3, 299

    CrossRef

  65. 65
    Mohamed I.F. Shariff, Shahid A. Khan, David Westaby, The palliation of cholangiocarcinoma, Current Opinion in Supportive and Palliative Care, 2013, 7, 2, 168

    CrossRef

  66. 66
    Christopher A. Wadsworth, Adrian Lim, Simon D. Taylor-Robinson, Shahid A. Khan, The risk factors and diagnosis of cholangiocarcinoma, Hepatology International, 2013, 7, 2, 377

    CrossRef

  67. 67
    Sung-Hye You, Yun Hwan Kim, Sung Bum Cho, Urnultsaikhan Ganbold, Soon Ho Um, Yeon Seok Seo, Jae Gol Choe, Two Cases of Unresectable Cholangiocarcinoma Treated by Yttrium-90 Microspheres, Journal of the Korean Society of Radiology, 2013, 69, 2, 143

    CrossRef

  68. 68
    Ivo Graziadei, Übersicht: Lebertumore, Wiener Medizinische Wochenschrift, 2013, 163, 5-6, 109

    CrossRef

  69. 69
    Florentina Mihalache, Aksana Höblinger, Monica Acalovschi, Tilman Sauerbruch, Frank Lammert, Vincent Zimmer, A common variant in the precursor miR-146a sequence does not predispose to cholangiocarcinoma in a large European cohort, Hepatobiliary & Pancreatic Diseases International, 2012, 11, 4, 412

    CrossRef

  70. 70
    Marco Marzioni, Alessia Torrice, Stefania Saccomanno, Chiara Rychlicki, Laura Agostinelli, Irene Pierantonelli, Patrik Rhönnstad, Luciano Trozzi, Theresa Apelqvist, Raffaele Gentile, Cinzia Candelaresi, Giammarco Fava, Rossella Semeraro, Antonio Benedetti, Eugenio Gaudio, Antonio Franchitto, Paolo Onori, Samuele De Minicis, Guido Carpino, Elisabet Kallin, Domenico Alvaro, Stefan Nilsson, An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma, Digestive and Liver Disease, 2012, 44, 2, 134

    CrossRef

  71. 71
    Jason Mulvenna, Ponlapat Yonglitthipagon, Banchob Sripa, Paul J. Brindley, Alex Loukas, Jeffrey M. Bethony, Banking on the future: Biobanking for “omics” approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand, Parasitology International, 2012, 61, 1, 173

    CrossRef

  72. 72
    Marc Pracht, Guillaume Le Roux, Laurent Sulpice, Habiba Mesbah, Sylvain Manfredi, Odile Audrain, Karim Boudjema, Jean-Luc Raoul, Eveline Boucher, Chemotherapy for Inoperable Advanced or Metastatic Cholangiocarcinoma: Retrospective Analysis of 78 Cases in a Single Center over Four Years, Chemotherapy, 2012, 58, 2, 134

    CrossRef

  73. 73
    Pawel K Mazur, Marc-Oliver Riener, Wolfram Jochum, Glen Kristiansen, Achim Weber, Roland M Schmid, Jens T Siveke, Expression and Clinicopathological Significance of Notch Signaling and Cell-Fate Genes in Biliary Tract Cancer, The American Journal of Gastroenterology, 2012, 107, 1, 126

    CrossRef

  74. 74
    Teijiro Hirashita, Yukio Iwashita, Masayuki Ohta, Yoko Komori, Hidetoshi Eguchi, Kazuhiro Yada, Seigo Kitano, Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma, Journal of Gastrointestinal Surgery, 2012, 16, 4, 842

    CrossRef

  75. 75
    Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong, Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta-analysis and systematic review, Journal of Gastroenterology and Hepatology, 2012, 27, 10
  76. 76
    Thorsten Lieke, Wolf Ramackers, Sabine Bergmann, Jürgen Klempnauer, Michael Winkler, Johannes Klose, Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro, BMC Cancer, 2012, 12, 1, 466

    CrossRef

  77. 77
    Sayaka Sekiya, Atsushi Suzuki, Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes, Journal of Clinical Investigation, 2012, 122, 11, 3914

    CrossRef

  78. 78
    Fang-Ming Gu, Qiang Gao, Guo-Ming Shi, Xin Zhang, Jiping Wang, Jia-Hao Jiang, Xiao-Ying Wang, Ying-Hong Shi, Zhen-Bin Ding, Jia Fan, Jian Zhou, Intratumoral IL-17+ Cells and Neutrophils show Strong Prognostic Significance in Intrahepatic Cholangiocarcinoma, Annals of Surgical Oncology, 2012, 19, 8, 2506

    CrossRef

  79. 79
    Benjamin R. Kipp, Jesse S. Voss, Sarah E. Kerr, Emily G. Barr Fritcher, Rondell P. Graham, Lizhi Zhang, W. Edward Highsmith, Jun Zhang, Lewis R. Roberts, Gregory J. Gores, Kevin C. Halling, Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma, Human Pathology, 2012, 43, 10, 1552

    CrossRef

  80. 80
    Jinqiang Zhang, Chang Han, Tong Wu, MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating β-catenin, Gastroenterology, 2012, 143, 1, 246

    CrossRef

  81. 81
    Xiang-yu Zhong, Jian-hua Yu, Wei-guang Zhang, Zhi-dong Wang, Qin Dong, Sheng Tai, Yun-fu Cui, Hui Li, MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression, Gene, 2012, 493, 1, 44

    CrossRef

  82. 82
    Puangrat Yongvanit, Somchai Pinlaor, Helmut Bartsch, Oxidative and nitrative DNA damage: Key events in opisthorchiasis-induced carcinogenesis, Parasitology International, 2012, 61, 1, 130

    CrossRef

  83. 83
    Yutaka Tomizawa, Jianmin Tian, Photodynamic Therapy for Unresectable Cholangiocarcinoma, Digestive Diseases and Sciences, 2012, 57, 2, 274

    CrossRef

  84. 84
    Sirintip Boonjaraspinyo, Thidarut Boonmars, Zhiliang Wu, Watcharin Loilome, Paiboon Sithithaworn, Isao Nagano, Somchai Pinlaor, Puangrat Yongvanit, Phuangphaka Sadee Nielsen, Chawalit Pairojkul, Narong Khuntikeo, Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma, Tumor Biology, 2012, 33, 5, 1785

    CrossRef

  85. 85
    Lena Sibulesky, Justin Nguyen, Tushar Patel, Preneoplastic conditions underlying bile duct cancer, Langenbeck's Archives of Surgery, 2012, 397, 6, 861

    CrossRef

  86. 86
    Ponlapat Yonglitthipagon, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi, Jason Mulvenna, Alex Loukas, Banchob Sripa, Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma, Clinical Biochemistry, 2012, 45, 10-11, 827

    CrossRef

  87. 87
    Stephen P. Pereira, Guruprasad P. Aithal, Krish Ragunath, John Devlin, Faye Owen, Helen Meadows, Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma, Photodiagnosis and Photodynamic Therapy, 2012, 9, 4, 287

    CrossRef

  88. 88
    Marion Haidu, Georg Dobrozemsky, Peter Schullian, Gerlig Widmann, Alexander Klaus, Helmut Weiss, Raimund Margreiter, Reto Bale, Stereotactic Radiofrequency Ablation of Unresectable Intrahepatic Cholangiocarcinomas: A Retrospective Study, CardioVascular and Interventional Radiology, 2012, 35, 5, 1074

    CrossRef

  89. 89
    Seung Hee Ha, Jong-Ho Hwang, Do Hyung Kim, Min-Dae Kim, Cheol-Woong Choi, Young-Il Jeong, Chung Wook Chung, Cy Hyun Kim, Dae Hwan Kang, Sunitinib release from biodegradable films of poly(l-lactide-co-caprolactone), Materials Research Bulletin, 2012, 47, 10, 2735

    CrossRef

  90. 90
    Christian D. Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse E. Sirica, Gregory J. Gores, Targeting PDGFR-β in Cholangiocarcinoma, Liver International, 2012, 32, 3
  91. 91
    Ioannis Papaconstantinou, Andreas Karakatsanis, Maria Gazouli, George Polymeneas, Dionissios Voros, The role of microRNAs in liver cancer, European Journal of Gastroenterology & Hepatology, 2012, 24, 3, 223

    CrossRef

  92. 92
    Lewis R. Roberts, Goldman's Cecil Medicine, 2012,

    CrossRef

  93. 93
    Hasan Kulaksiz, Pavel Strnad, Achim Römpp, Guido von Figura, Thomas Barth, Irene Esposito, Peter Schirmacher, Doris Henne-Bruns, Guido Adler, Adolf Stiehl, A Novel Method of Forceps Biopsy Improves the Diagnosis of Proximal Biliary Malignancies, Digestive Diseases and Sciences, 2011, 56, 2, 596

    CrossRef

  94. 94
    Zhiliang Wu, Thidarut Boonmars, Sirintip Boonjaraspinyo, Isao Nagano, Somchai Pinlaor, Anucha Puapairoj, Puangrat Yongvanit, Yuzo Takahashi, Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection, Parasitology Research, 2011, 109, 3, 657

    CrossRef

  95. 95
    Jordi Bruix, Maria Reig, Jordi Rimola, Alejandro Forner, Marta Burrel, Ramón Vilana, Carmen Ayuso, Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques, Hepatology, 2011, 54, 6
  96. 96
    Boris Blechacz, Mina Komuta, Tania Roskams, Gregory J. Gores, Clinical diagnosis and staging of cholangiocarcinoma, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 9, 512

    CrossRef

  97. 97
    Hyun Jong Choi, Jong Ho Moon, Bong Min Ko, Seul Ki Min, A. Ri Song, Tae Hoon Lee, Young Koog Cheon, Young Deok Cho, Sang-Heum Park, Clinical feasibility of direct peroral cholangioscopy–guided photodynamic therapy for inoperable cholangiocarcinoma performed by using an ultra-slim upper endoscope (with videos), Gastrointestinal Endoscopy, 2011, 73, 4, 808

    CrossRef

  98. 98
    Ning-fu Peng, Le-qun Li, Xiao Qin, Ya Guo, Tao Peng, Kai-yin Xiao, Xi-gang Chen, Yu-feng Yang, Zhi-xiong Su, Bin Chen, Ming Su, Lu-nan Qi, Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus, Annals of Surgical Oncology, 2011, 18, 5, 1258

    CrossRef

  99. 99
    Jaime Feliu, Javier Sastre, Joan Maurel, Dolores Isla, Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines, Clinical and Translational Oncology, 2011, 13, 8, 536

    CrossRef

  100. 100
    F. Mihalache, A. Höblinger, F. Grünhage, M. Krawczyk, B. C. Gärtner, M. Acalovschi, T. Sauerbruch, F. Lammert, V. Zimmer, Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma, Alimentary Pharmacology & Therapeutics, 2011, 33, 3
  101. 101
    Yavuz Beyazit, Tugrul Purnak, Burak Suvak, Mevlut Kurt, Abdurrahim Sayilir, Turan Turhan, Adnan Tas, Serkan Torun, Tugrul Celik, Mehmet Ibis, Ibrahim C. Haznedaroglu, Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 10, 644

    CrossRef

  102. 102
    Min Wang, Juan Xiao, Min Shen, Yu Yahong, Rui Tian, Feng Zhu, Jianxin Jiang, Zhiyong Du, Jun Hu, Wensong Liu, Renyi Qin, Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties, International Journal of Cancer, 2011, 128, 1
  103. You have full text access to this Open Access content103
    Seiji Shio, Yuzo Kodama, Hiroshi Ida, Masahiro Shiokawa, Koji Kitamura, Etsuro Hatano, Shinji Uemoto, Tsutomu Chiba, Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis, Cancer Science, 2011, 102, 4
  104. 104
    Tania M. Welzel, Barry I. Graubard, Stefan Zeuzem, Hashem B. El-Serag, Jessica A. Davila, Katherine A. McGlynn, Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database, Hepatology, 2011, 54, 2
  105. 105
    Alexandru V. Olaru, Gabriel Ghiaur, Sumitaka Yamanaka, Delgermaa Luvsanjav, Fangmei An, Irinel Popescu, Sorin Alexandrescu, Sarah Allen, Timothy M. Pawlik, Michael Torbenson, Christos Georgiades, Lewis R. Roberts, Gregory J. Gores, Anne Ferguson-Smith, Maria I. Almeida, George A. Calin, Esteban Mezey, Florin M. Selaru, MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint, Hepatology, 2011, 54, 6
  106. 106
    Zenta Walther, Dhanpat Jain, Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance, Pathology Research International, 2011, 2011, 1

    CrossRef

  107. 107
    Christian D. Fingas, Steven F. Bronk, Nathan W. Werneburg, Justin L. Mott, Maria E. Guicciardi, Sophie C. Cazanave, Joachim C. Mertens, Alphonse E. Sirica, Gregory J. Gores, Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells, Hepatology, 2011, 54, 6
  108. 108
    Luca Fabris, Massimiliano Cadamuro, Lidia Moserle, James Dziura, Xiangyu Cong, Luisa Sambado, Giorgia Nardo, Aurelio Sonzogni, Michele Colledan, Alberto Furlanetto, Nicolò Bassi, Marco Massani, Umberto Cillo, Claudia Mescoli, Stefano Indraccolo, Massimo Rugge, Lajos Okolicsanyi, Mario Strazzabosco, Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization, Hepatology, 2011, 54, 3
  109. 109
    Banchob Sripa, Jeffrey M. Bethony, Paiboon Sithithaworn, Sasithorn Kaewkes, Eimorn Mairiang, Alex Loukas, Jason Mulvenna, Thewarach Laha, Peter J. Hotez, Paul J. Brindley, Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos, Acta Tropica, 2011, 120, S158

    CrossRef

  110. 110
    Dong Xun Zhou, Hao Wang, HuaBang Zhou, Shuangxi Li, Hai Xia Qu, XiaoXia Kou, JingZe Li, Hui Wang, He Ping Hu, Over-expression of human carcinoma-associated antigen in intrahepatic cholangiocellular carcinoma, Biochemical and Biophysical Research Communications, 2011, 405, 2, 325

    CrossRef

  111. 111
    Juan Wang, Xuefeng Wang, Shuyang Xie, Zhonghai Yan, Zunling Li, Youjie Li, Lei Wang, Fei Jiao, p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies, Digestive Diseases and Sciences, 2011, 56, 3, 655

    CrossRef

  112. 112
    Yasuni Nakanuma, Jing Xu, Kenichi Harada, Yasunori Sato, Motoko Sasaki, Hiroko Ikeda, Jihun Kim, Eunsil Yu, Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases, Pathology International, 2011, 61, 5
  113. 113
    Hiroaki Sugiyama, Kenichiro Onuki, Kazunori Ishige, Nobue Baba, Tetsuya Ueda, Sachiko Matsuda, Kaoru Takeuchi, Masafumi Onodera, Yasuni Nakanuma, Masayuki Yamato, Masakazu Yamamoto, Ichinosuke Hyodo, Junichi Shoda, Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells, Journal of Gastroenterology, 2011, 46, 6, 779

    CrossRef

  114. 114
    Kirsten Muri Boberg, Guro E. Lind, Primary sclerosing cholangitis and malignancy, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 753

    CrossRef

  115. 115
    M Miyamoto, H Ojima, M Iwasaki, H Shimizu, A Kokubu, N Hiraoka, T Kosuge, D Yoshikawa, T Kono, H Furukawa, T Shibata, Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma, British Journal of Cancer, 2011, 105, 1, 131

    CrossRef

  116. 116
    Timothy Miller, Fuquan Yang, Candace E. Wise, Fanyin Meng, Sally Priester, Md Kamruzzaman Munshi, Micheleine Guerrier, David E. Dostal, Shannon S. Glaser, Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity, Digestive and Liver Disease, 2011, 43, 5, 395

    CrossRef

  117. 117
    Antonello A. Romani, Silvia Desenzani, Marina M. Morganti, Maria Cristina Baroni, Angelo F. Borghetti, Paolo Soliani, The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid, Cancer Chemotherapy and Pharmacology, 2011, 67, 3, 557

    CrossRef

  118. 118
    Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra, Abdominal Imaging, 2011,

    CrossRef

  119. 119
    Christian D. Fingas, Boris R. A. Blechacz, Rory L. Smoot, Maria E. Guicciardi, Justin Mott, Steve F. Bronk, Nathan W. Werneburg, Alphonse E. Sirica, Gregory J. Gores, A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells, Hepatology, 2010, 52, 2
  120. 120
    Eveline Boucher, Marc Pracht, Catherine Roux, Karim Boudjema, Jean-Luc Raoul, Adjuvant treatment after resection of biliary-tract cancer: yes or no?, Oncology Reviews, 2010, 4, 3, 167

    CrossRef

  121. 121
    Tobias Kiesslich, Daniel Neureiter, Gernot W Wolkersdörfer, Kristjan Plaetzer, Frieder Berr, Advances in photodynamic therapy for the treatment of hilar biliary tract cancer, Future Oncology, 2010, 6, 12, 1925

    CrossRef

  122. 122
    Johan Fevery, Chris Verslype, An update on cholangiocarcinoma associated with primary sclerosing cholangitis, Current Opinion in Gastroenterology, 2010, 26, 3, 236

    CrossRef

  123. 123
    Domenico Alvaro, Renato Cannizzaro, Roberto Labianca, Francesca Valvo, Fabio Farinati, Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO), Digestive and Liver Disease, 2010, 42, 12, 831

    CrossRef

  124. 124
    Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro, Cholangiocarcinoma: Update and future perspectives, Digestive and Liver Disease, 2010, 42, 4, 253

    CrossRef

  125. 125
    Marco Marzioni, Stefania Saccomanno, Cinzia Candelaresi, Chiara Rychlicki, Laura Agostinelli, Luciano Trozzi, Samuele De Minicis, Antonio Benedetti, Clinical implications of novel aspects of biliary pathophysiology, Digestive and Liver Disease, 2010, 42, 4, 238

    CrossRef

  126. 126
    Benjamin R. Kipp, Emily G. Barr Fritcher, Amy C. Clayton, Gregory J. Gores, Lewis R. Roberts, Jun Zhang, Michael J. Levy, Kevin C. Halling, Comparison of KRAS Mutation Analysis and FISH for Detecting Pancreatobiliary Tract Cancer in Cytology Specimens Collected During Endoscopic Retrograde Cholangiopancreatography, The Journal of Molecular Diagnostics, 2010, 12, 6, 780

    CrossRef

  127. 127
    Domenico Alvaro, Emanuele Crocetti, Stefano Ferretti, Maria Consiglia Bragazzi, Riccardo Capocaccia, Descriptive epidemiology of cholangiocarcinoma in Italy, Digestive and Liver Disease, 2010, 42, 7, 490

    CrossRef

  128. You have full text access to this Open Access content128
    Hai-Rim Shin, Jin-Kyoung Oh, Eric Masuyer, Maria-Paula Curado, Veronique Bouvard, Yue-Yi Fang, Surapon Wiangnon, Banchob Sripa, Sung-Tae Hong, Epidemiology of cholangiocarcinoma: An update focusing on risk factors, Cancer Science, 2010, 101, 3
  129. 129
    HuaBang Zhou, Hui Wang, DongXun Zhou, Hao Wang, Qing Wang, ShanShan Zou, QianQian Tu, MengChao Wu, HePing Hu, Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis, European Journal of Cancer, 2010, 46, 6, 1056

    CrossRef

  130. 130
    Dong Kuang, Guo-Ping Wang, Hilar cholangiocarcinoma: Pathology and tumor biology, Frontiers of Medicine in China, 2010, 4, 4, 371

    CrossRef

  131. 131
    Ramón Vilana, Alejandro Forner, Luis Bianchi, Ángeles García-Criado, Jordi Rimola, Carlos Rodríguez de Lope, María Reig, Carmen Ayuso, Concepció Brú, Jordi Bruix, Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound, Hepatology, 2010, 51, 6
  132. 132
    A. Tsubota, K. Matsumoto, K. Mogushi, K. Nariai, Y. Namiki, S. Hoshina, H. Hano, H. Tanaka, H. Saito, N. Tada, IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress, Carcinogenesis, 2010, 31, 3, 504

    CrossRef

  133. 133
    Sanjay Y. Bangarulingam, Einar Bjornsson, Felicity Enders, Emily G. Barr Fritcher, Gregory Gores, Kevin C. Halling, Keith D. Lindor, Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis, Hepatology, 2010, 51, 1
  134. 134
    Chiara Braconi, Nianyuan Huang, Tushar Patel, MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes, Hepatology, 2010, 51, 3
  135. 135
    Chien Peter Chen, Daphne Haas-Kogan, Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics, Expert Review of Molecular Diagnostics, 2010, 10, 7, 883

    CrossRef

  136. 136
    Antonio Franchitto, Alessia Torrice, Rossella Semeraro, Cristina Napoli, Gennaro Nuzzo, Felice Giuliante, Gianfranco Alpini, Guido Carpino, Pasquale Bartolomeo Berloco, Luciano Izzo, Antonio Bolognese, Paolo Onori, Anastasia Renzi, Alfredo Cantafora, Eugenio Gaudio, Domenico Alvaro, Prostate Apoptosis Response-4 Is Expressed in Normal Cholangiocytes, Is Down-Regulated in Human Cholangiocarcinoma, and Promotes Apoptosis of Neoplastic Cholangiocytes When Induced Pharmacologically, The American Journal of Pathology, 2010, 177, 4, 1779

    CrossRef

  137. 137
    Gianpaolo Carrafiello, Domenico Laganà, Elisa Cotta, Monica Mangini, Federico Fontana, Francesca Bandiera, Carlo Fugazzola, Radiofrequency Ablation of Intrahepatic Cholangiocarcinoma: Preliminary Experience, CardioVascular and Interventional Radiology, 2010, 33, 4, 835

    CrossRef

  138. 138
    Bunliang Suphim, Auemduan Prawan, Upa Kukongviriyapan, Sarinya Kongpetch, Benjaporn Buranrat, Veerapol Kukongviriyapan, Redox modulation and human bile duct cancer inhibition by curcumin, Food and Chemical Toxicology, 2010, 48, 8-9, 2265

    CrossRef

  139. 139
    M. Tanaka, H. Tanaka, H. Tsukuma, A. Ioka, A. Oshima, T. Nakahara, Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus, Journal of Viral Hepatitis, 2010, 17, 10
  140. 140
    Shang-Long Liu, Zi-Fang Song, Qing-Gang Hu, Duo Shan, Shao-Bo Hu, Jun Li, Qi-Chang Zheng, Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis, Frontiers of Medicine in China, 2010, 4, 4, 457

    CrossRef

  141. 141
    D. Hariharan, V.A. Constantinides, F.E.M. Froeling, P.P. Tekkis, H.M. Kocher, The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers – A meta-analysis, European Journal of Surgical Oncology (EJSO), 2010, 36, 10, 941

    CrossRef

  142. 142
    Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg, Update on primary sclerosing cholangitis, Digestive and Liver Disease, 2010, 42, 6, 390

    CrossRef

  143. 143
    Akshat Saxena, Lourens Bester, Terence C. Chua, Francis C. Chu, David L. Morris, Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option, Annals of Surgical Oncology, 2010, 17, 2, 484

    CrossRef

  144. 144
    Boris Blechacz, Gregory J. Gores, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  145. 145
    Kris V. Kowdley, Netter's Gastroenterology, 2010,

    CrossRef

  146. 146
    JAMES M. CRAWFORD, CHEN LIU, Robbins and Cotran Pathologic Basis of Disease, 2010,

    CrossRef

  147. 147
    Jay H. Lefkowitch, Scheuer's Liver Biopsy Interpretation, 2010,

    CrossRef

  148. 148
    Jordi Rimola, Alejandro Forner, Maria Reig, Ramon Vilana, Carlos Rodríguez de Lope, Carmen Ayuso, Jordi Bruix, Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma, Hepatology, 2009, 50, 3
  149. 149
    Ron R. Allison, Emmanuel Zervos, Claudio H. Sibata, Cholangiocarcinoma: An emerging indication for photodynamic therapy, Photodiagnosis and Photodynamic Therapy, 2009, 6, 2, 84

    CrossRef

  150. 150
    Nathalie Guedj, Qian Zhan, Martine Perigny, Pierre-Emmanuel Rautou, Françoise Degos, Jacques Belghiti, Olivier Farges, Pierre Bedossa, Valérie Paradis, Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas, Journal of Hepatology, 2009, 51, 1, 93

    CrossRef

  151. 151
    Liang-qi Cao, Ping Xue, Hai-wu Lu, Qiang Zheng, Zi-long Wen, Zhi-jian Shao, Hematoporphyrin derivative-mediated photodynamic therapy inhibits tumor growth in human cholangiocarcinoma in vitro and in vivo, Hepatology Research, 2009, 39, 12
  152. 152
    Richard A. Kozarek, Inflammation and Carcinogenesis of the Biliary Tract: Update On Endoscopic Treatment, Clinical Gastroenterology and Hepatology, 2009, 7, 11, S89

    CrossRef

  153. 153
    Florin M. Selaru, Alexandru V. Olaru, Takatsugu Kan, Stefan David, Yulan Cheng, Yuriko Mori, Jian Yang, Bogdan Paun, Zhe Jin, Rachana Agarwal, James P. Hamilton, John Abraham, Christos Georgiades, Hector Alvarez, Perumal Vivekanandan, Wayne Yu, Anirban Maitra, Michael Torbenson, Paul J. Thuluvath, Gregory J. Gores, Nicholas F. LaRusso, Ralph Hruban, Stephen J. Meltzer, MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3, Hepatology, 2009, 49, 5
  154. 154
    Justin L. Mott, MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia, Hepatology, 2009, 50, 2
  155. 155
    Kia Homayounfar, Bastian Gunawan, Silke Cameron, Florian Haller, Daniel Baumhoer, Stefan Uecker, Bjoern Sander, Giuliano Ramadori, Thomas Lorf, László Füzesi, Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization, Human Pathology, 2009, 40, 6, 834

    CrossRef

  156. 156
    Annarita Farina, Jean-Marc Dumonceau, Pierre Lescuyer, Proteomic analysis of human bile and potential applications for cancer diagnosis, Expert Review of Proteomics, 2009, 6, 3, 285

    CrossRef

  157. 157
    Jay H. Lefkowitch, Recent developments in liver pathology, Human Pathology, 2009, 40, 4, 445

    CrossRef

  158. 158
    Domenico Alvaro, Serum and bile biomarkers for cholangiocarcinoma, Current Opinion in Gastroenterology, 2009, 25, 3, 279

    CrossRef

  159. 159
    Boris R. A. Blechacz, Rory L. Smoot, Steven F. Bronk, Nathan W. Werneburg, Alphonse E. Sirica, Gregory J. Gores, Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2, Hepatology, 2009, 50, 6
  160. 160
    C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen, S Y Hsieh, Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma, British Journal of Cancer, 2009, 100, 11, 1765

    CrossRef

  161. 161
    Antonello A. Romani, Silvia Desenzani, Marina M. Morganti, Silvia La Monica, Angelo F. Borghetti, Paolo Soliani, Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells, Biochemical Pharmacology, 2009, 78, 2, 133

    CrossRef

  162. 162
    Diaa H. Elfaki, Andrea A. Gossard, Keith D. Lindor, Cholangiocarcinoma: Expanding the Spectrum of Risk Factors, Journal of Gastrointestinal Cancer, 2008, 39, 1-4, 114

    CrossRef

  163. 163
    Jayant A. Talwalkar, Keith D. Lindor, Autoimmune Liver Diseases,
  164. 164
    Annarita Farina, Myriam Delhaye, Pierre Lescuyer, Jean-Marc Dumonceau, Bile Proteome in Health and Disease, Comprehensive Physiology,
  165. 165
    Erin W. Thackeray, William Sanchez, Biliary Strictures and Leaks,
  166. 166
    Konstantinos N. Lazaridis, Gregory J. Gores, Cholangiocarcinoma,
  167. 167
    Patricia Munoz-Garrido, Marco Marzioni, Elizabeth Hijona, Luis Bujanda, Jesus M. Banales, MicroRNAs in Liver Diseases,